Navigating the Pharmaceutical Benefits Scheme: federal versus state government funding for high-cost medicines – a problem for public hospitals.

MLA

Misko, Jeanie, et al. “Navigating the Pharmaceutical Benefits Scheme: Federal versus State Government Funding for High-Cost Medicines – a Problem for Public Hospitals.” Australian Health Review : A Publication of the Australian Hospital Association, vol. 46, no. 3, June 2022, pp. 316–18. EBSCOhost, https://doi.org/10.1071/AH22002.

APA

Misko, J., Jenkins, B., & Rawlins, M. (2022). Navigating the Pharmaceutical Benefits Scheme: federal versus state government funding for high-cost medicines – a problem for public hospitals. Australian Health Review : A Publication of the Australian Hospital Association, 46(3), 316–318. https://doi.org/10.1071/AH22002

Chicago

Misko, Jeanie, Barry Jenkins, and Matt Rawlins. 2022. “Navigating the Pharmaceutical Benefits Scheme: Federal versus State Government Funding for High-Cost Medicines – a Problem for Public Hospitals.” Australian Health Review : A Publication of the Australian Hospital Association 46 (3): 316–18. doi:10.1071/AH22002.